ZEB2 and acute myeloid leukemia: However, simultaneous deletion of both murine Zeb2 and Zeb1 in murine MLL-AF9 AML settings was found to significantly increase the overall survival of mice transplanted with MLL-AF9 secondary tumor cells compared with nontreated vehicle-treated controls [130].